Asthma and COPD overlap syndrome (ACOS): A systematic review and meta analysis

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Alshabanat, A ^a,d   Zafari, Z ^b   Albanyan, O ^c   Dairi, M ^a   FitzGerald, J M ^a,b,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH   (Canada)

^c KING FAHAD SPECIALIST HOSPITAL   (Saudi Arabia)

^d Lung Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

AGE DISTRIBUTION; ARTICLE; ASTHMA; ASTHMA AND COPD OVERLAP SYNDROME; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; EXERCISE TOLERANCE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; LUNG FUNCTION; PREVALENCE; QUALITY OF LIFE; SEX RATIO; SMOKING; SYSTEMATIC REVIEW; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; LUNG FUNCTION TEST; META ANALYSIS; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ASTHMA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 84947426984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136065     Document Type: Article

References (46)

1. The Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. Available: http://www.ginasthma.org/
2. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. Available: http://www.goldcopd.org/
3. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003; 124: 474-481. PMID: 12907531
4. Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1(3):176-83. PMID: 16113432
5. Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS) Global Initiative for Asthma (GINA) 2014. Available: http://www.ginasthma.org/
6. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126(1):59-65. PMID: 15249443
7. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64:728-35. doi: 10.1136/thx.2008.108027 PMID: 19638566
8. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. BMJ 2009; 339:b2535, doi: 10.1136/bmj.b2535 PMID: 19622551
9. Wells GA SB, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available: http://www.ohri. ca/programs/clinical-epidemiology/oxford.htm. Accessed 19 February 2014.
10. Shirtcliffe P, Marsh S, Travers J, Weatherall M, Beasley R. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J 2012; 42(1):83-8. doi: 10.1111/j.1445-5994.2010.02238.x PMID: 20403069
11. Menezes AM, Montes de Oca M, Pérez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPDAsthma. Chest 2014; 145(2):297-304. doi: 10.1378/chest.13-0622 PMID: 24114498
12. Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM, et al. Proportional classifications of COPD phenotypes. Thorax 2008; 63(9):761-7. doi: 10.1136/thx.2007.089193 PMID: 18728201
13. Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpeläinen M, Kinnula VL, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011; 48(3):279-85. doi: 10.3109/02770903.2011.555576 PMID: 21323613
14. Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011; 12:127. doi: 10.1186/1465-9921-12-127 PMID: 21951550
15. Izquierdo-Alonso JL, Rodriguez-Gonzálezmoro JM, de Lucas-Ramos P, Unzueta I, Ribera X, Antón E, et al. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Respir Med 2013; 107(5):724-31. doi: 10.1016/j.rmed.2013.01.001 PMID: 23419828
16. Johannessen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005; 9(8):926-32. PMID: 16104642
17. Danielsson P, Ólafsdóttir IS, Benediktsdóttir B, Gíslason T, Janson C. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden-the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Clin Respir J 2012; 6(2):120-7. doi: 10.1111/j.1752-699X.2011.00257.x PMID: 21651748
18. Methvin JN, Mannino DM, Casey BR. COPD prevalence in southeastern Kentucky: the burden of lung disease study. Chest 2009; 135(1):102-7. doi: 10.1378/chest.08-1315 PMID: 18689574
19. Miravitlles M, Soriano JB, Ancochea J, Muñoz L, Duran-Tauleria E, Sánchez G, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med 2013; 107(7):1053-60. doi: 10.1016/j.rmed.2013.03.007 PMID: 23597591
20. Zhou Y, Wang C, Yao W, Chen P, Kang J, Huang S, et al. COPD in Chinese nonsmokers. Eur Respir J 2009; 33(3):509-18. doi: 10.1183/09031936.00084408 PMID: 19251797
21. Jyrki-Tapani K, Sovijärvi A, Lundbäck B. Chronic obstructive pulmonary disease in Finland: prevalence and risk factors. COPD 2005; 2(3):331-9. PMID: 17146998
22. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2003 Feb 1; 167(3):418-24. Epub 2002 Nov 8. PMID: 12426229
23. Rhee CK, Yoon HK, Yoo KH, Kim YS, Lee SW, Park YB, et al. Medical Utilization and Cost in Patients with Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Asthma. COPD. 2013; 11 (2):163-70. doi: 10.3109/15412555.2013.831061 PMID: 24111662
24. Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm 2008; 14(2):176-85. PMID: 18331119
25. de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One 2013; 8(5):e62985. doi: 10.1371/journal.pone.0062985 PMID: 23675448
26. Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008; 134(1):14-9. doi: 10.1378/chest.07-2317 PMID: 18339789
27. Fu JJ, McDonald VM, Gibson PG, Simpson JL. Systemic inflammation in older adults with asthma-COPD overlap syndrome. Allergy Asthma Immunol Res. 2014 July; 6(4):316-324. doi: 10.4168/aair.2014.6.4.316 PMID: 24991455
28. Vasankari TM, Impivaara O, Heliövaara M, Heistaro S, Liippo K, Puukka P. No increase in the prevalence of COPD in two decades. Eur Respir J 2010; 36(4):766-73. doi: 10.1183/09031936.00178109 PMID: 20693258
29. Shahab L, Jarvis M J, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006; 61(12):1043-1047. PMID: 17040932
30. Bridevaux PO, Probst-Hensch NM, Schindler C, Curjuric I, Felber Dietrich D, Braendli O, et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J 2010; 36 (6):1259-69. doi: 10.1183/09031936.00004110 PMID: 20413537
31. Behrendt CE. Mild and Moderate-to-Severe COPD in Nonsmokers. Chest 2005; 128(3):1239-44. PMID: 16162712
32. Hagstad S, Ekerljung L, Lindberg A, Backman H, Rönmark E, Lundbäck B. COPD among non-smokers-report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med 2012; 106 (7):980-8. doi: 10.1016/j.rmed.2012.03.010 PMID: 22498109
33. Lamprecht B, Schirnhofer L, Kaiser B, Buist S, Studnicka M. Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study. Respir Med. 2008; 102(12):1833-8. doi: 10.1016/j.rmed.2008.07.007 PMID: 18722100
34. Gershon A, Guan J, Victor JC, Wang C, To T. The course of asthma activity: a population study. J Allergy Clin Immunol 2012; 129(3):679-86. doi: 10.1016/j.jaci.2011.11.014 PMID: 22178637
35. Pinto Pereira LM, Bartholomew LA, Brooks H, Lowe D, Rocke K, Rolle S, et al. Chronic obstructive pulmonary disease is missed in asthmatics in specialty care in Trinidad, West Indies. Int J Tuberc Lung Dis 2007; 11(9):1026-32. PMID: 17705983
36. Andersén H, Lampela P, Nevanlinna A, Säynäjäkangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J 2013; 7(4):342-6. doi: 10.1111/crj.12013 PMID: 23362945
37. Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD 2011; 8(6):400-7. doi: 10.3109/15412555.2011.611200 PMID: 22149399
38. Meyer PA, Mannino DM, Redd SC, Olson DR. Characteristics of adults dying with COPD. Chest 2002; 122(6):2003-2008. PMID: 12475839
39. Panizza JA, James AL, Ryan G, de Klerk N, Finucane KE. Mortality and airflow obstruction in asthma: a 17-year follow-up study. Intern Med J 2006; 36(12):773-780. PMID: 17096740
40. Lundbäck B, Eriksson B, Lindberg A, Ekerljung L, Muellerova H, Larsson LG, et al. A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies. COPD 2009; 6(4):263-71. PMID: 19811385
41. Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. COPD 2007; 4(2):127-134. PMID: 17530506
42. Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002; 20: 819-825. PMID: 12412670
43. Martinez F J, Standiford C, Gay S E. "Is it asthma or COPD? The answer determines proper therapy for chronic airflow obstruction". Postgraduate Medicine. 2005; 117(3):19-26. PMID: 15782670
44. Miravitlles M, Soler-Cataluña JJ, Calle M, Soriano JB. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J 2013; 41(6):1252-6. doi: 10.1183/09031936.00118912 Epub 2012 Oct 11.PMID: 23060631
45. Lim HS, Choi SM, Lee J, Park YS, Lee SM, Yim JJ, et al. Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome. Ann Allergy Asthma Immunol. 2014 Dec; 113(6):652-7. doi: 10.1016/j.anai.2014.08.021 Epub 2014 Oct 3.PMID: 25280465
46. Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respiratory Medicine (2008) 102, 50-56. PMID: 17920256